225 related articles for article (PubMed ID: 32747636)
21. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
Aihara T; Fujiwara Y; Ooka M; Sakita I; Tamaki Y; Monden M
Breast Cancer Res Treat; 1999 Nov; 58(2):137-40. PubMed ID: 10674878
[TBL] [Abstract][Full Text] [Related]
22. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
[TBL] [Abstract][Full Text] [Related]
23. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.
Tjensvoll K; Oltedal S; Heikkilä R; Kvaløy JT; Gilje B; Reuben JM; Smaaland R; Nordgård O
BMC Cancer; 2012 May; 12():190. PubMed ID: 22640166
[TBL] [Abstract][Full Text] [Related]
24. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
[TBL] [Abstract][Full Text] [Related]
26. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bregni M; Fleischhauer K; Bernardi M; Pescarollo A; Guggiari E; Lunghi F; Deola S; Scaramuzza S; Re F; Setola E; Monari M; Mazzi B; Servida P; Corradini P; Peccatori J
Bone Marrow Transplant; 2006 Feb; 37(3):311-5. PubMed ID: 16400340
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow micrometastases in breast cancer patients.
Simmons R; Hoda S; Osborne M
Am J Surg; 2000 Oct; 180(4):309-12. PubMed ID: 11113442
[TBL] [Abstract][Full Text] [Related]
29. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma.
Han JH; Kang Y; Shin HC; Kim HS; Kang YM; Kim YB; Oh SY
Arch Pathol Lab Med; 2003 Oct; 127(10):1330-4. PubMed ID: 14521461
[TBL] [Abstract][Full Text] [Related]
30. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
31. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
[TBL] [Abstract][Full Text] [Related]
32. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
[TBL] [Abstract][Full Text] [Related]
33. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
35. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
[TBL] [Abstract][Full Text] [Related]
36. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.
Fleming TP; Watson MA
Ann N Y Acad Sci; 2000; 923():78-89. PubMed ID: 11193781
[TBL] [Abstract][Full Text] [Related]
37. Mammaglobin 1: not only a breast-specific and tumour-specific marker, but also a hormone-responsive endometrial protein.
Classen-Linke I; Moss S; Gröting K; Beier HM; Alfer J; Krusche CA
Histopathology; 2012 Nov; 61(5):955-65. PubMed ID: 22994369
[TBL] [Abstract][Full Text] [Related]
38. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
[TBL] [Abstract][Full Text] [Related]
39. Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression.
Semesiuk NI; Zhylchuk A; Bezdenezhnykh N; Lykhova A; Vorontsova AL; Zhylchuk VE; Kudryavets YI
Exp Oncol; 2013 Dec; 35(4):295-302. PubMed ID: 24382441
[TBL] [Abstract][Full Text] [Related]
40. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
Yang Z
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
